SAM
MED icon

Shell Asset Management’s Medifast MED Stock Holding History

Shell Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,547
Closed -$171K – 1286
2023
Q4 		$171K Sell
2,547
-763
-23% -$53.2K 0.01% 908
2023
Q3 		$248K Sell
3,310
-51
-2% -$4.53K 0.01% 828
2023
Q2 		$310K Sell
3,361
-2,165
-39% -$193K 0.01% 772
2023
Q1 		$573K Buy
5,526
+4,297
+350% +$476K 0.02% 509
2022
Q4 		$142K Sell
1,229
-273
-18% -$31.8K 0.01% 1068
2022
Q3 		$163K Sell
1,502
-398
-21% -$57K 0.01% 1075
2022
Q2 		$343K Buy
1,900
+1,164
+158% +$208K 0.01% 915
2022
Q1 		$126K Sell
736
-108
-13% -$20.4K ﹤0.01% 1258
2021
Q4 		$177K Buy
844
+4
+0.5% +$827 ﹤0.01% 1237
2021
Q3 		$162K Sell
840
-30
-3% -$7.38K ﹤0.01% 1244
2021
Q2 		$246K Buy
+870
New +$236K ﹤0.01% 1178

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Shell Asset Management's MED Position: Q1 2024 in Review

Shell Asset Management sold out of Medifast (MED) in Q1 2024, closing a stake of 2,547 shares — an estimated $171K sold.

Shell Asset Management first reported a position in MED in Q2 2021 and held it in 11 quarters. The position peaked at $573K in Q1 2023. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Shell Asset Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Shell Asset Management sold 2,547 Medifast shares in Q1 2024, an estimated $171K.
  • Shell Asset Management first reported a position in Medifast in Q2 2021 and held it in 11 quarters.
  • Shell Asset Management's Medifast position peaked at $573K in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Shell Asset Management's 13F filing for Q1 2024, filed 14 May 2024.